01705oam 2200457 450 991070255470332120141217114704.0(CKB)5470000002428631(OCoLC)887720599(EXLCZ)99547000000242863120140818d2014 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierReforming the drug compounding regulatory framework hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013Washington :U.S. Government Printing Office,2014.1 online resource (vi, 190 pages)Title from title screen (viewed on Aug. 18, 2014).Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office."Serial No. 113-70."Includes bibliographical references.Reforming the drug compounding regulatory framework DrugsDosage formsUnited StatesPharmaceutical industryUnited StatesDrug adulterationUnited StatesPreventionLegislative hearings.lcgftDrugsDosage formsPharmaceutical industryDrug adulterationPrevention.GPOGPOGPOCOOOCLCOGPOBOOK9910702554703321Reforming the drug compounding regulatory framework3501961UNINA